Assessing the Suitability of a Virtual ‘Pink Warrior’ for Older Breast Cancer Survivors during COVID-19: A Pilot Study

Author:

Swartz Maria C.1ORCID,Robertson Michael C.2ORCID,Christopherson Ursela2,Wells Stephanie J.1,Lewis Zakkoyya H.3ORCID,Bai Jinbing4ORCID,Swartz Michael D.5,Silva H. Colleen6,Martinez Eloisa7,Lyons Elizabeth J.2

Affiliation:

1. Department of Pediatrics Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

2. Department of Nutrition, Metabolism & Rehabilitation Sciences, The University of Texas Medical Branch, Galveston, TX 77550, USA

3. Department of Kinesiology & Health Promotion, California State Polytechnic University, Pomona, CA 91768, USA

4. Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA 30322, USA

5. Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health, Houston, TX 77030, USA

6. Department of Surgery, The University of Texas Medical Branch, Galveston, TX 77550, USA

7. Sealy Center on Aging, The University of Texas Medical Branch, Galveston, TX 77550, USA

Abstract

The COVID-19 pandemic impacted the conduct of in-person physical activity (PA) interventions among older survivors of BC, who need such interventions to stay active and prevent functional decline. We tested the feasibility of virtually delivering an exergame-based PA intervention to older BC survivors. We enrolled 20 female BC survivors ≥55 years and randomly assigned them to two groups. The intervention group (Pink Warrior 2) received 12 weekly virtual exergame sessions with behavioral coaching, survivorship navigation support, and a Fitbit for self-monitoring. The control group received 12 weekly phone-based survivorship discussion sessions and wore a Mi Band 3. Feasibility was evaluated by rates of recruitment (≥0.92 participants/center/month), retention (≥80%), and group attendance (≥10 sessions), percentage of completed virtual assessments, and number of technology-related issues and adverse events. Intervention acceptability was measured by participants’ ratings on a scale of 1 (strongly disagree) to 5 (strongly agree). The recruitment rate was 1.93. The retention and attendance rates were 90% and 88% (≥10 sessions), respectively. Ninety-six percent completed virtual assessments without an adverse event. Acceptability was high (≥4). The intervention met benchmarks for feasibility. Additional research is needed to further understand the impact of virtually delivered PA interventions on older BC survivors.

Funder

UTMB Claude D. Pepper Older Americans Independence Center NIH

Cancer Center Support Grant

Publisher

MDPI AG

Subject

Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics

Reference79 articles.

1. What cancer survivorship means;Sulik;AMA J. Ethics,2013

2. American Cancer Society (2022, August 24). Cancer Treatment & Survivorship Facts & Figures 2022–2024. Available online: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/2022-cancer-treatment-and-survivorship-fandf-acs.pdf.

3. The Intersection of Cancer and Aging: Establishing the Need for Breast Cancer Rehabilitation;Schmitz;Cancer Epidemiol. Biomark. Prev.,2007

4. Cespedes Feliciano, E.M., Vasan, S., Luo, J., Binder, A.M., Chlebowski, R.T., Quesenberry, C., Banack, H.R., Caan, B.J., Paskett, E.D., and Williams, G.R. (2023). Long-term Trajectories of Physical Function Decline in Women with and without Cancer. JAMA Oncol.

5. Long-term Prognostic Role of Functional Limitations Among Women With Breast Cancer;Braithwaite;JNCI J. Natl. Cancer Inst.,2010

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3